Download PDF
Schlaf 2013; 02(01): 30-35
DOI: 10.1055/s-0038-1626040
Review
Schattauer GmbH

Jetlag

Grundlagen und Behandlungsansätze
Daniel Aeschbach
Further Information

Publication History

Publication Date:
10 February 2018 (online)

    Permissions and Reprints

Jetlag ist eine zirkadiane Schlaf-Wach-Rhythmusstörung, die nach Flügen in eine andere Zeitzone auftritt. Zu den Jetlagsymptomen zählen v.a. Schlafstörungen, Tagesschläfrigkeit, beeinträchtigte Leistungsfähigkeit und Stimmung sowie gastrointestinale Beschwerden.

 

  • Literatur

  • 1 American Academy of Sleep Medicine. International classification of sleep disorders: diagnostic and coding manual. American Academy of Sleep Medicine. 2013
    PubMedGoogle Scholar
  • 2 Deutsche Gesellschaft für Schlafforschung und Schlafmedizin. Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 2009; 13: 4-160.
    CrossrefGoogle Scholar
  • 3 Czeisler CA, Duffy JF, Shanahan TL, Brown EN, Mitchell JF, Rimmer DW. et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999; 284 (5423) 2177-2181.
    CrossrefPubMedGoogle Scholar
  • 4 Rosenberg RP, Bogan RK, Tiller JM, Yang R, Youakim JM, Earl CQ. et al. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc 2010; 85 (07) 630-638.
    CrossrefPubMedGoogle Scholar
  • 5 Arendt J. Managing jet lag: Some of the problems and possible new solutions. Sleep Med Rev 2009; (13) 249-56.
    PubMedGoogle Scholar
  • 6 Sack RL. Jet Lag. The New England Journal of Medicine 2010; 362 (05) 440-447.
    CrossrefPubMedGoogle Scholar
  • 7 Sack RL, Auckley D, Auger R, Carskadon MA, Wright Jr. KP. Circadian rhythm sleep disorders: part I, basic principles, shift work and jet lag disorders. Sleep 2007; 30 (11) 1460-1483.
    CrossrefPubMedGoogle Scholar
  • 8 Revell VL, Eastman CI. How to trick mother nature into letting you fly around or stay up all night. J Biol Rhythms 2005; 20 (04) 353-365.
    CrossrefPubMedGoogle Scholar
  • 9 Buscemi N, Vandermeer B, Hooton N, Pandya R, Tjosvold L, Hartling L. et al. Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. Brit Med J 2006; 332 (7538) 385-393.
    CrossrefPubMedGoogle Scholar
  • 10 Aeschbach D, Lockyer BJ, Dijk DJ, Lockley SW, Nuwayser ES, Nichols LD. et al. Use of transdermal melatonin delivery to improve sleep maintenance during daytime. Clinical Pharmacol Ther 2009; 86 (01) 378-382.
    CrossrefPubMedGoogle Scholar
  • 11 Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G. et al. Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet 2009; 373: 482-491.
    CrossrefPubMedGoogle Scholar
  • 12 Zee PC, Wang-Weigant S, Wright Jr. KP, Peng X, Roth T. Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. Sleep Med 2010; 11: 525-533.
    CrossrefPubMedGoogle Scholar
  • 13 Samel A, Wegmann HM, Vejvoda M, Maass H, Gundel A, Schutz M. Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hr time shift. J Biol Rhythms 1991; 6 (03) 235-248.
    CrossrefPubMedGoogle Scholar
  • 14 Viola AU, Archer SN, James LM, Groeger JA, Lo JC, Skene DJ. et al. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol 2007; 17 (07) 613-618.
    CrossrefPubMedGoogle Scholar